E-LIB Suche - Ergebnisse für: Ouzan, D.

1

Changing HCV patient profiles: insights from a large multin..:

Mangia, A. ; Fagiuoli, S. ; Di Marco, V....
Digestive and Liver Disease. 55 (2023) - p. S71-S72 , 2023

Link: https://doi.org/10.1016/..

2

Retreatment with Direct Active Antivirals of genotype 1, 3 ..:

Halfon, P. ; Scholtes, C. ; Izopet, J....
Journal of Hepatology. 66 (2017) 1 - p. S730-S731 , 2017

Link: https://doi.org/10.1016/..

3

Retreatment of hepatitis C virus daa failures in real life:..:

Ouzan, D. ; Penaranda, G. ; Lefolgoc, G....
Journal of Hepatology. 66 (2017) 1 - p. S304 , 2017

Link: https://doi.org/10.1016/..

4

Effectiveness of Peginterferon Alfa-2a Therapy in HBeAg-Pos..:

Marcellin, P. ; Xie, Q. ; Paik, S.W....
Journal of Hepatology. 64 (2016) 2 - p. S598-S599 , 2016

Link: https://doi.org/10.1016/..

5

AVDLIB 2: News Direct-Acting Antiviral (DDA) in HCV Patient..:

Ouzan, D. ; Penaranda, G. ; Delasalle, P....
Journal of Hepatology. 64 (2016) 2 - p. S400-S401 , 2016

Link: https://doi.org/10.1016/..

6

HEP-09 - Description de la population incluse dans l'autori..:

Asselah, T. ; Ouzan, D. ; Hillaire, S..
Médecine et Maladies Infectieuses. 46 (2016) 4 - p. 53 , 2016

Link: https://doi.org/10.1016/..

7

Viral Suppression is Not a risk Factor for CKD in Viral Cir..:

Bagnis, C.I. ; Layese, R. ; Divard, G....
Journal of Hepatology. 64 (2016) 2 - p. S256 , 2016

Link: https://doi.org/10.1016/..

8

New Recommendations of Baveno Vi Conference for the Screeni..:

Thabut, D. ; Bureau, C. ; Layese, R....
Journal of Hepatology. 64 (2016) 2 - p. S178 , 2016

Link: https://doi.org/10.1016/..

9

Efficacy and Safety of IFN Free, Direct-Acting Antiviral-Ba..:

Ouzan, D. ; Penaranda, G. ; Delasalle, P....
Journal of Hepatology. 64 (2016) 2 - p. S401 , 2016

Link: https://doi.org/10.1016/..

10

Extrahepatic Cancer is the Second Cause of Non Liver-Relate..:

Allaire, M. ; Bourcier, V. ; Layese, R....
Journal of Hepatology. 64 (2016) 2 - p. S273 , 2016

Link: https://doi.org/10.1016/..

11

Prevalence and Characterization of NS5A Resistance Associat..:

Halfon, P. ; Scholtès, C. ; Mohamed, S....
Journal of Hepatology. 64 (2016) 2 - p. S408 , 2016

Link: https://doi.org/10.1016/..

12

Prospective Evidence That Hepatocellular Carcinoma Surveill..:

Costentin, C. ; Layese, R. ; Bourcier, V....
Journal of Hepatology. 64 (2016) 2 - p. S194-S195 , 2016

Link: https://doi.org/10.1016/..

13

The Benefits of Virosuppression on Progression of Portal Hy..:

Bureau, C. ; Thabut, D. ; Layese, R....
Journal of Hepatology. 64 (2016) 2 - p. S655-S656 , 2016

Link: https://doi.org/10.1016/..

14

P0822 : Safety And efficacy of sofosbuvir containing regime..:

Ouzan, D. ; Fontanges, T. ; Pénaranda, G....
Journal of Hepatology. 62 (2015) - p. S645 , 2015

Link: https://doi.org/10.1016/..

15

P0328 : Incidence, characteristics and determinants of prim..:

Nahon, P. ; Bourcier, V. ; Layese, R....
Journal of Hepatology. 62 (2015) - p. S432 , 2015

Link: https://doi.org/10.1016/..